Okuda DT - Search Results

1

Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovation.

Oh J, Airas L, Harrison D, Järvinen E, Livingston T, Lanker S, Malik RA, Okuda DT, Villoslada P, de Vries HE. Oh J, et al. Among authors: okuda dt. Front Neurol. 2023 Dec 1;14:1319869. doi: 10.3389/fneur.2023.1319869. eCollection 2023. Front Neurol. 2023. PMID: 38107636 Free PMC article. Review.

2

Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.

Thouvenot E, Hinsinger G, Demattei C, Uygunoglu U, Castelnovo G, Pittion-Vouyovitch S, Okuda D, Kantarci O, Pelletier D, Lehmann S, Marin P, Siva A, Lebrun C. Thouvenot E, et al. Mult Scler. 2019 Apr;25(5):669-677. doi: 10.1177/1352458518767043. Epub 2018 Mar 22. Mult Scler. 2019. PMID: 29564952

3

Focal lesion in the splenium of the corpus callosum.

Okuda DT. Okuda DT. Arch Neurol. 2008 Jun;65(6):849. doi: 10.1001/archneur.65.6.849-a. Arch Neurol. 2008. PMID: 18541816 No abstract available.

4

Naegleria fowleri meningoencephalitis.

Okuda DT, Coons S. Okuda DT, et al. Neurology. 2003 Jul 8;61(1):E1. doi: 10.1212/01.wnl.0000058759.01260.d8. Neurology. 2003. PMID: 12847187 No abstract available.

5

Looking beyond head trauma.

Okuda DT. Okuda DT. Science. 2008 Nov 21;322(5905):1186. doi: 10.1126/science.322.5905.1186a. Science. 2008. PMID: 19023059 No abstract available.

6

Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.

Lebrun C, Cohen M, Pignolet B, Seitz-Polski B, Bucciarelli F, Benzaken S, Kantarci O, Siva A, Okuda D, Pelletier D, Brassat D; on behalf SFSEP, BIONAT Network; RISC. Lebrun C, et al. J Neurol Sci. 2016 Sep 15;368:334-6. doi: 10.1016/j.jns.2016.07.052. Epub 2016 Jul 25. J Neurol Sci. 2016. PMID: 27538659

7

High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients.

Metcalf M, Xu D, Okuda DT, Carvajal L, Srinivasan R, Kelley DA, Mukherjee P, Nelson SJ, Vigneron DB, Pelletier D. Metcalf M, et al. Among authors: okuda dt. J Neuroimaging. 2010 Apr;20(2):141-7. doi: 10.1111/j.1552-6569.2008.00338.x. Epub 2009 Jan 29. J Neuroimaging. 2010. PMID: 19187478 Free PMC article.

8

Recurrent asymptomatic demyelinating disease following 13-cis-retinoic acid exposure.

Okuda DT, Prados MD. Okuda DT, et al. BMJ Case Rep. 2009;2009:bcr05.2009.1908. doi: 10.1136/bcr.05.2009.1908. Epub 2009 Sep 8. BMJ Case Rep. 2009. PMID: 21901115 Free PMC article.

9

Regional grey matter atrophy in clinically isolated syndromes at presentation.

Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D. Henry RG, et al. Among authors: okuda dt. J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1236-44. doi: 10.1136/jnnp.2007.134825. Epub 2008 May 9. J Neurol Neurosurg Psychiatry. 2008. PMID: 18469033 Free PMC article.

10

Acute pathological laughter.

Okuda DT, Chyung AS, Chin CT, Waubant E. Okuda DT, et al. Mov Disord. 2005 Oct;20(10):1389-90. doi: 10.1002/mds.20607. Mov Disord. 2005. PMID: 16007658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page